DIPG-35. BIOLOGICAL MEDICINE FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) ERADICATION: RESULTS OF THE THREE ARM BIOMARKER-DRIVEN RANDOMIZED BIOMEDE 1.0 TRIAL

Despite 50 years of clinical trials, no improvement of survival has been observed in DIPG and most children die within 2 years of diagnosis. Only radiotherapy transiently controls disease progression. The study was conceived as a randomized multi-arm multi-stage program. It started with an open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Grill, Jacques, Teuff, Gwenael Le, Nysom, Karsten, Blomgren, Klas, Hargrave, Darren, MacCowage, Geoff, Bautista, Francisco, Van Vuurden, Dannis, Dangouloff-Ros, Volodia, Puget, Stephanie, Varlet, Pascale, Debily, Marie-Anne, Vassal, Gilles, Deley, Marie-Cecile Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Diffuse Midline Glioma/DIPG
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715776/
http://dx.doi.org/10.1093/neuonc/noaa222.083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715776/
http://dx.doi.org/10.1093/neuonc/noaa222.083

Ejemplares similares